48
Growth Score in past quarter
pts
Heat Score 48 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1307103
LIPAC Oncology is a clinical-stage drug delivery company.
Ramachandran R. Thirucote: CEO & CHAIRMAN
About the Company
LIPAC Oncology is a clinical-stage drug delivery company focused on developing unique localized therapies to treat cancer in challenging parts of the body. It’s breakthrough technology addresses shortcomings of current treatments for Bladder Cancer, Upper Tract Urothelial Carcinoma and Stage II/III Ovarian Cancer.